Actinium Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q2 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Actinium Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2012 to Q3 2024.
  • Actinium Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -47.9 %, a 3.49% increase year-over-year.
  • Actinium Pharmaceuticals, Inc. annual Return On Assets for 2023 was -52.6 %, a 70.1% decline from 2022.
  • Actinium Pharmaceuticals, Inc. annual Return On Assets for 2022 was -30.9 %, a 1.18% decline from 2021.
  • Actinium Pharmaceuticals, Inc. annual Return On Assets for 2021 was -30.6 %, a 37.7% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -47.9 +1.73 +3.49% Jul 1, 2024 Sep 30, 2024
Q2 2024 -48.9 -6.01 -14% Apr 1, 2024 Jun 30, 2024
Q1 2024 -51.9 -17.7 -51.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -52.6 -21.7 -70.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -49.6 -18.7 -60.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -42.9 -12.6 -41.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -34.2 -3.87 -12.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -30.9 -0.36 -1.18% Oct 1, 2022 Dec 31, 2022
Q3 2022 -30.9 -1.05 -3.52% Jul 1, 2022 Sep 30, 2022
Q2 2022 -30.3 +1.94 +6.02% Apr 1, 2022 Jun 30, 2022
Q1 2022 -30.4 +4.91 +13.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -30.6 +18.5 +37.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -29.8 +34.8 +53.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -32.2 +61 +65.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -35.3 +115 +76.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -49 +92.2 +65.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -64.6 +80.1 +55.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -93.2 +50.2 +35% Apr 1, 2020 Jun 30, 2020
Q1 2020 -151 -9.94 -7.07% Jan 1, 2020 Mar 31, 2020
Q4 2019 -141 -24.8 -21.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -145 -38.6 -36.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 -143 -43.4 -43.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -141 -18.1 -14.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -116 +32.9 +22.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -106 +43 +28.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -99.9 +60.1 +37.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -123 +18.1 +12.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -149 -34.4 -30% Oct 1, 2017 Dec 31, 2017
Q3 2017 -149 -40.2 -36.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 -160 -70.9 -79.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -141 -52.3 -59.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -115 -29.1 -33.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -109 -8.09 -8.03% Jul 1, 2016 Sep 30, 2016
Q2 2016 -89.1 +43.4 +32.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -88.3 -8.77 -11% Jan 1, 2016 Mar 31, 2016
Q4 2015 -85.8 +148 +63.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -101 +148 +59.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 -132 +125 +48.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 -79.5 +405 +83.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -234 -6.22 -2.73% Oct 1, 2014 Dec 31, 2014
Q3 2014 -249 -84.9 -51.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -258 -5.82 -2.31% Apr 1, 2014 Jun 30, 2014
Q1 2014 -485 -129 -36.1% Jan 1, 2014 Mar 31, 2014
Q4 2013 -228 +350 +60.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 -164 +190 +53.6% Jul 1, 2013 Sep 30, 2013
Q2 2013 -252 -91.8 -57.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -356 Jan 1, 2013 Mar 31, 2013
Q4 2012 -578 Oct 1, 2012 Dec 31, 2012
Q3 2012 -354 Jul 1, 2012 Sep 30, 2012
Q2 2012 -160 Apr 1, 2012 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.